CLVS
Neuberger Berman Group’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-16,000
| Closed | -$397K | – | 1597 |
|
|
2019
Q1 | $397K | Buy |
+16,000
| New | +$397K | ﹤0.01% | 1300 |
|
|
2018
Q3 | – | Sell |
-23,406
| Closed | -$1.06M | – | 1719 |
|
|
2018
Q2 | $1.06M | Buy |
+23,406
| New | +$1.06M | ﹤0.01% | 1212 |
|
|
2017
Q4 | – | Sell |
-11,000
| Closed | -$906K | – | 1826 |
|
|
2017
Q3 | $906K | Buy |
+11,000
| New | +$906K | ﹤0.01% | 1170 |
|
|
2015
Q4 | – | Sell |
-160,959
| Closed | -$14.8M | – | 1584 |
|
|
2015
Q3 | $14.8M | Buy |
160,959
+152,170
| +1,731% | +$14M | 0.02% | 706 |
|
|
2015
Q2 | $772K | Buy |
+8,789
| New | +$772K | ﹤0.01% | 1247 |
|
|
2013
Q4 | – | Sell |
-4,800
| Closed | -$292K | – | 1675 |
|
|
2013
Q3 | $292K | Buy |
4,800
+1,687
| +54% | +$103K | ﹤0.01% | 1409 |
|
|
2013
Q2 | $209K | Buy |
+3,113
| New | +$209K | ﹤0.01% | 1484 |
|